Theravance Biopharma (TBPH)

Add to Watchlists
Create an Alert
18.39 +0.06  +0.33% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
TBPH Price Chart
View All Events

TBPH Events

Date Type Description
08/13/2014 Earnings Theravance Biopharma Inc 2014 Q2 Earning Release
View All Performance Charts

TBPH Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Theravance Biopharma is up N/A over the last year vs S&P 500 Total Return up 15.04%, Theravance down 14.54%, and Keryx Biopharmaceuticals down 18.65%.

Get Quote for

TBPH Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: Cayman Islands
  • HQ State/Province: N/A
  • Incorporation Country: Cayman Islands
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: N/A
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Theravance Biopharma Inc is engaged in discovery (research), development and commercialization of human therapeutics.

TBPH Excel Add-In Codes

  • Name: =YCI("TBPH","name")
  • Description: =YCI("TBPH","description")
  • Sector: =YCI("TBPH","sector")
  • Industry: =YCI("TBPH","industry")
  • Est. Current Fiscal Year End: =YCI("TBPH","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.